

Revvity (RVTY) hits a new 52-week high after topping Q3 earnings estimates and raising its full-year guidance on strong biotech and AI demand.
You can purchase shares of Revvity (NYSE:RVTY) through any online brokerage.
Other companies in Revvity’s space includes: Thermo Fisher Scientific Inc (NYSE:TMO), Danaher Corp (NYSE:DHR), Agilent Technologies Inc (NYSE:A), Waters Corp (NYSE:WAT) and IQVIA Holdings Inc (NYSE:IQV).
Revvity has a consensus price target of $130.50.
The stock price for Revvity (NYSE: RVTY) is $150.83 last updated November 5, 2026 at 5:23 PM EST.
There are no upcoming dividends for Revvity.
Revvity does not have any upcoming earnings scheduled.
There is no upcoming split for Revvity.
Revvity is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NYSE.
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and...